433 related articles for article (PubMed ID: 26428507)
1. Preeclampsia, biomarkers, syncytiotrophoblast stress, and placental capacity.
Redman CW; Staff AC
Am J Obstet Gynecol; 2015 Oct; 213(4 Suppl):S9.e1, S9-11. PubMed ID: 26428507
[TBL] [Abstract][Full Text] [Related]
2. IFPA Senior Award Lecture: making sense of pre-eclampsia - two placental causes of preeclampsia?
Redman CW; Sargent IL; Staff AC
Placenta; 2014 Feb; 35 Suppl():S20-5. PubMed ID: 24477207
[TBL] [Abstract][Full Text] [Related]
3. Syncytiotrophoblast stress in preeclampsia: the convergence point for multiple pathways.
Redman CWG; Staff AC; Roberts JM
Am J Obstet Gynecol; 2022 Feb; 226(2S):S907-S927. PubMed ID: 33546842
[TBL] [Abstract][Full Text] [Related]
4. In vivo uteroplacental release of placental growth factor and soluble Fms-like tyrosine kinase-1 in normal and preeclamptic pregnancies.
Holme AM; Roland MC; Henriksen T; Michelsen TM
Am J Obstet Gynecol; 2016 Dec; 215(6):782.e1-782.e9. PubMed ID: 27503620
[TBL] [Abstract][Full Text] [Related]
5. Differential 5'-tRNA Fragment Expression in Circulating Preeclampsia Syncytiotrophoblast Vesicles Drives Macrophage Inflammation.
Cooke WR; Jiang P; Ji L; Bai J; Jones GD; Lo YMD; Redman C; Vatish M
Hypertension; 2024 Apr; 81(4):876-886. PubMed ID: 38362745
[TBL] [Abstract][Full Text] [Related]
6. A review of the mechanism for poor placentation in early-onset preeclampsia: the role of autophagy in trophoblast invasion and vascular remodeling.
Saito S; Nakashima A
J Reprod Immunol; 2014 Mar; 101-102():80-88. PubMed ID: 23969229
[TBL] [Abstract][Full Text] [Related]
7. Why is placentation abnormal in preeclampsia?
Fisher SJ
Am J Obstet Gynecol; 2015 Oct; 213(4 Suppl):S115-22. PubMed ID: 26428489
[TBL] [Abstract][Full Text] [Related]
8. Reduced placental protein 13 (PP13) in placental derived syncytiotrophoblast extracellular vesicles in preeclampsia - A novel tool to study the impaired cargo transmission of the placenta to the maternal organs.
Sammar M; Dragovic R; Meiri H; Vatish M; Sharabi-Nov A; Sargent I; Redman C; Tannetta D
Placenta; 2018 Jun; 66():17-25. PubMed ID: 29884298
[TBL] [Abstract][Full Text] [Related]
9. Metformin as a prevention and treatment for preeclampsia: effects on soluble fms-like tyrosine kinase 1 and soluble endoglin secretion and endothelial dysfunction.
Brownfoot FC; Hastie R; Hannan NJ; Cannon P; Tuohey L; Parry LJ; Senadheera S; Illanes SE; Kaitu'u-Lino TJ; Tong S
Am J Obstet Gynecol; 2016 Mar; 214(3):356.e1-356.e15. PubMed ID: 26721779
[TBL] [Abstract][Full Text] [Related]
10. Loss of Thrombomodulin in Placental Dysfunction in Preeclampsia.
Turner RJ; Bloemenkamp KW; Bruijn JA; Baelde HJ
Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):728-35. PubMed ID: 26891741
[TBL] [Abstract][Full Text] [Related]
11. Syncytiotrophoblast stress in early onset preeclampsia: The issues perpetuating the syndrome.
Carrasco-Wong I; Aguilera-Olguín M; Escalona-Rivano R; Chiarello DI; Barragán-Zúñiga LJ; Sosa-Macías M; Galaviz-Hernandez C; San Martín S; Gutiérrez J
Placenta; 2021 Sep; 113():57-66. PubMed ID: 34053733
[TBL] [Abstract][Full Text] [Related]
12. Prospective study of placental angiogenic factors and maternal vascular function before and after preeclampsia and gestational hypertension.
Noori M; Donald AE; Angelakopoulou A; Hingorani AD; Williams DJ
Circulation; 2010 Aug; 122(5):478-87. PubMed ID: 20644016
[TBL] [Abstract][Full Text] [Related]
13. Pathophysiology of placentation abnormalities in pregnancy-induced hypertension.
Furuya M; Ishida J; Aoki I; Fukamizu A
Vasc Health Risk Manag; 2008; 4(6):1301-13. PubMed ID: 19337544
[TBL] [Abstract][Full Text] [Related]
14. Vascular dysfunction in preeclampsia.
Brennan LJ; Morton JS; Davidge ST
Microcirculation; 2014 Jan; 21(1):4-14. PubMed ID: 23890192
[TBL] [Abstract][Full Text] [Related]
15. Preeclampsia and syncytiotrophoblast membrane extracellular vesicles (STB-EVs).
Awoyemi T; Cerdeira AS; Zhang W; Jiang S; Rahbar M; Logenthiran P; Redman C; Vatish M
Clin Sci (Lond); 2022 Dec; 136(24):1793-1807. PubMed ID: 36511102
[TBL] [Abstract][Full Text] [Related]
16. Gelsolin is an endogenous inhibitor of syncytiotrophoblast extracellular vesicle shedding in pregnancy.
Nadkarni NA; Rajakumar A; Mokhashi N; Burke SD; Rana S; Salahuddin S; Dang Q; Thadhani R; Krishnan R; Stossel TP; Karumanchi SA
Pregnancy Hypertens; 2016 Oct; 6(4):333-339. PubMed ID: 27939478
[TBL] [Abstract][Full Text] [Related]
17. The effect of labour and placental separation on the shedding of syncytiotrophoblast microparticles, cell-free DNA and mRNA in normal pregnancy and pre-eclampsia.
Reddy A; Zhong XY; Rusterholz C; Hahn S; Holzgreve W; Redman CW; Sargent IL
Placenta; 2008 Nov; 29(11):942-9. PubMed ID: 18834630
[TBL] [Abstract][Full Text] [Related]
18. Bioactive factors in uteroplacental and systemic circulation link placental ischemia to generalized vascular dysfunction in hypertensive pregnancy and preeclampsia.
Shah DA; Khalil RA
Biochem Pharmacol; 2015 Jun; 95(4):211-26. PubMed ID: 25916268
[TBL] [Abstract][Full Text] [Related]
19. Dysregulation of anti-angiogenic agents (sFlt-1, PLGF, and sEndoglin) in preeclampsia--a step forward but not the definitive answer.
Foidart JM; Schaaps JP; Chantraine F; Munaut C; Lorquet S
J Reprod Immunol; 2009 Nov; 82(2):106-11. PubMed ID: 19853925
[TBL] [Abstract][Full Text] [Related]
20. The two-stage placental model of preeclampsia: An update.
Staff AC
J Reprod Immunol; 2019 Sep; 134-135():1-10. PubMed ID: 31301487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
